The Hordaland Health Studies (HHS)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 36,000
- 主要终点
- Total mortality.
研究概览
简要总结
The Hordaland Health Studies (HHS) were conducted in 1992-93 (The Homocysteine study) and in 1997-99 (HUSK). Both surveys were conducted as a joint project between the University of Bergen, the Norwegian Health Screening Service (SHUS) (now part of the National Institute of Public Health) and the Municipal Health Service in Hordaland.
The main focus of the studies is on chronic diseases including cardiovascular disease, cancer, osteoporosis, anxiety and depression. Some projects focus on psychosocial factors, occupational research, musculoskeletal diseases, urinary incontinence and mapping of drug use. The main purpose of the surveys is to gather information so that disease ultimately can be prevented.
Approximately 36,000 residents of Hordaland county participated in the studies, ca. 18,000 in 1992-93 and ca. 26,000 in 1997-99. About 7,000 of those who participated in the 1992-93 survey also participated in 1997-99.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Born in a specific time-period
- •From Hordaland County
- •Community-dwelling people who were able to come to the study site on their own, and able to fill out questionnaires.
排除标准
- •Not born within the specific time-period
- •Not from Hordaland County
- •Institutionalized People
- •People who were not able to fill out questionnaires
结局指标
主要结局
Total mortality.
时间窗: Participants are followed from baseline (1992-93 or 1997-99) until death or December 31st, 2015.
The unique 11-digit personal identification number assigned to all Norwegian residents facilitates linkage between HHS and the Norwegian Population Register, which contains information on vital status (alive, emigrated, or dead). The follow-up period varies from 16 - 23 years, depending on whether first or second measurement is used as baseline.
次要结局
- Mortality or morbidity from chronic diseases (for example cardiovascular disease, cancer). Also, award of disability pension are used as an outcome.(Participants are followed from baseline (1992-93 or 1997-99) until time of diagnosis/death from disease or the last day of follow-up.)
研究者
Grethe Seppola Tell
Professor
University of Bergen